IVI Announces Publication of Top Three Winners of Valuing Innovation Project Call for Papers

Alexandria, VA – July 9, 2024 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, is pleased to announce the release of a special supplement of PharmacoEconomics which features the Valuing Innovation Project (VIP) Call for Papers awardee manuscripts.

This special supplement features three articles that propose novel and practical solutions to help us better define, measure, and reward innovations in HTA frameworks. These papers were selected from a call for papers as part of the Valuing Innovation Project (VIP), a multi-phase initiative launched by IVI and multi-stakeholder partners.

Innovation and Value Initiative

Innovation and Value Initiative

“This research is a testament to the incredible progress being made in health technology assessment,” said Richard Chapman, PhD, IVI's Chief Science Officer. “These papers provide novel methods and frameworks that will help us more accurately measure and reward the value of medical innovations, encouraging further innovation that will ultimately benefit patients and healthcare systems globally.”

The three winning manuscripts, available online ahead of print in the Journal of PharmacoEconomics, are:

“It will be critical to test and refine these innovative approaches in future healthcare assessments,” Chapman added. “We look forward to seeing these methods adopted and making a real-world impact.”

Learn more.

Related Content
CH LogoCenter for Biosimilars Logo